Pharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.
Specialty medications dominate
Last month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
Generic drugs produced $227 billion in savings for the U.S. healthcare system in 2015
While FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs.
An exclusive Associated Press report found that Medicare’s spending on certain drugs soared by 85% in two years.
New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.
Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
FDA approves a new indication, then issues strengthened warning about possible effects.